Welcome to our dedicated page for Enhabit SEC filings (Ticker: EHAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Medicare reimbursement tables, patient-day metrics, and hospice turnover data are scattered across hundreds of pages of Enhabit’s disclosures. If parsing those figures in the latest Enhabit annual report 10-K simplified seems daunting, you’re not alone. Healthcare accounting rules create footnotes that read like another language. Stock Titan’s AI turns that language into clear insights, making Enhabit SEC filings explained simply. Whether you’re scanning for regulatory risks or auditing segment margins, our platform surfaces what matters before you wade through dense jargon.
Need the next Enhabit quarterly earnings report 10-Q filing or an alert on Enhabit Form 4 insider transactions real-time? Our engine pulls every document the moment it hits EDGAR and delivers AI-powered summaries in seconds. Investors searching for:
- Enhabit insider trading Form 4 transactions
- Enhabit proxy statement executive compensation
- Enhabit 8-K material events explained
- Enhabit earnings report filing analysis
receive a single dashboard that connects each form to real questions: What did executives buy, how did home-health margins shift, and did CMS rule changes impact revenue guidance?
Understanding Enhabit SEC documents with AI also means context. Our tools highlight hospice census trends, regional payor mixes, and quality-of-care metrics buried deep in footnotes. Curious about Enhabit executive stock transactions Form 4 ahead of a rate update? Want a red-lined comparison that shows how the new filing differs from last year? Stock Titan provides real-time updates, side-by-side comparisons, and plain-English explanations, so you can decide faster, act sooner, and focus on the fundamentals driving home-health performance.
Enhabit, Inc. received a joint Schedule 13G/A reporting that a group of related investment entities and an individual, collectively the "Reporting Persons," hold 3,853,067 shares of Enhabit common stock, representing 7.61% of the outstanding class based on 50,637,417 shares outstanding. The holdings are held across affiliated vehicles: 8 Knots Fund (2,035,999 shares, 4.02%), 8 Knots Fund II (170,645 shares, 0.34%), and other affiliated entities that together account for the aggregate position.
The filing identifies 8 Knots Management, LLC as an SEC-registered investment adviser and names Scott Green as its managing member; 8 Knots Management and Mr. Green disclaim beneficial ownership of certain sub-advised and separately managed account positions, while acknowledging shared voting and dispositive power over the disclosed aggregate position. The filing includes a joint filing agreement among the Reporting Persons and a certification that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control.
Solomon Ryan, Enhabit’s Chief Financial Officer, reported acquiring 10,000 shares of Enhabit common stock on 08/08/2025 at $7.64 per share (transaction code 'P', acquisition flag 'A'). The report shows his direct beneficial ownership increased to 193,468 shares. No derivative securities were reported in the filing.
Enhabit, Inc. (EHAB) Form 4 filed 08/07/2025 discloses an insider purchase. EVP of Hospice Operations Jeanne L. Kalvaitis acquired 22,795 shares of common stock on 08/05/2025 at an indicated price of $6.69 under transaction code “A” (award or purchase). Following the transaction, her direct ownership doubled to 45,979 shares.
No derivative transactions were reported. The filing reflects a single-person submission with direct ownership only and contains no additional remarks or explanations.
FAQ
What is the current stock price of Enhabit (EHAB)?
What is the market cap of Enhabit (EHAB)?
